Registry of Lobbyists

Monthly Communication Reports in: January 2021

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Innovative Medicines Canada/Médicaments novateurs Canada

Pamela Fralick, President (Organization)

Results 1-8 of 8

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Luc Thériault, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-29
    Posted date: 2021-02-10
    Communication number: 371-494745 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-21
    Posted date: 2021-02-10
    Communication number: 371-494744 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jason Easton, Chief of Staff | Minister of Small Business, Export Promotion and International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-20
    Posted date: 2021-02-10
    Communication number: 371-494743 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-18
    Posted date: 2021-02-10
    Communication number: 371-494741 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate Deputy Minister | Canada Drug Agency | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-01-15
    Posted date: 2021-02-10
    Communication number: 371-494732 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Amanda Woodley, Special Assistant (Policy)/Assistant (Parliamentary Secretary) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-15
    Posted date: 2021-02-10
    Communication number: 371-494738 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hendrik Brakel, Director of Policy | Office of the Leader of the Opposition, MP Erin O’Toole | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2021-01-07
    Posted date: 2021-02-10
    Communication number: 371-494734 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marcel Saulnier, Associate Deputy Minister | Canada Drug Agency | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2021-01-06
    Posted date: 2021-02-10
    Communication number: 371-494729 View associated registration

Return to Monthly Communication Reports by Reporting Period

Date Modified: